Agenus Reports Landmark 3-Year OS Data for BOT+BAL in Refractory MSS mCRC at ESMO GI
Prostate Cancer: New ESTRO Recommendations for Precision Radiotherapy
Monica Bertagnolli: Don't Abolish the NIH, Fix It
ESTRO Sets Practical Guidance for Focal Boosting in Prostate Cancer Radiotherapy 2026
BOT/BAL Shows 33% 3-Year OS in Refractory MSS mCRC Without Active Liver Metastases
Can SABR Replace Surgery in Selected Low-Risk Breast Cancer?
Daraxonrasib for Pancreatic Cancer: What’s Next?
Felicia Marie Knaul: WHO to Present First Global Estimates of 5-Year Breast Cancer Survival
The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024. It will offer valuable insights for […]
4th How to Diagnose and Treat: CML/MPN will be held at Vienna, Austria from March 7-9, 2025. ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and […]
5th How to Diagnose and Treat: Multiple Myeloma will be held at Vienna Austria from April 3-5, 2025. ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to […]
4th Translational Research Conference: Acute Lymphoblastic Leukaemia will be held at Malahide (Dublin), Ireland from May 22-24, 2025. ESH Translational Research Conference programs are tailored to highlight the latest advancements in basic, clinical, and therapeutic research, with a focus on future developments in the field. These conferences are structured to provide extensive opportunities for in-depth […]
